☰

Zhongqi Dong, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Sciences University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Pharmacy, Public Health, Epidemiology
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Dong Z, Li Q, Guo D, Shu Y, Polli JE. Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver. Journal of Pharmaceutical Sciences. PMID 25645375 DOI: 10.1002/Jps.24375  0.537
2015 Dong Z, Ekins S, Polli JE. A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. International Journal of Pharmaceutics. 478: 88-95. PMID 25448570 DOI: 10.1016/J.Ijpharm.2014.11.022  0.553
2014 Dong Z, Ekins S, Polli JE. Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 66: 1-9. PMID 25220493 DOI: 10.1016/J.Ejps.2014.09.005  0.563
2013 Li Q, Guo D, Dong Z, Zhang W, Zhang L, Huang SM, Polli JE, Shu Y. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). Toxicology and Applied Pharmacology. 273: 100-9. PMID 24001450 DOI: 10.1016/J.Taap.2013.08.024  0.528
2013 Li Q, Yang H, Peng X, Guo D, Dong Z, Polli JE, Shu Y. Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1. Molecular Pharmaceutics. 10: 2578-87. PMID 23651427 DOI: 10.1021/Mp400013T  0.551
2013 Dong Z, Ekins S, Polli JE. Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Molecular Pharmaceutics. 10: 1008-19. PMID 23339484 DOI: 10.1021/Mp300453K  0.568
Show low-probability matches.